FDA Extends Mifepristone Safety Review Into 2027
The FDA told a federal court its mifepristone safety review will run into 2027, with a report due by March. Timeline, context and what changes now.
The FDA told a federal court its mifepristone safety review will run into 2027, with a report due by March. Timeline, context and what changes now.